Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Trump's Iran sanctions: Why India's rice, pharma exports are at risk
3 min read New Delhi Make us preferred source on Google The US has launched a sweeping new campaign to isolate Iran economically, warning foreign companies and countries that continue doing business with Tehran that they could face sanctions and…
LSL PHARMA GROUP REPORTS RECORD REVENUES AND SECOND QUARTER 2026 RESULTS
Record quarterly revenues from both the CMO and Private Label business segments; Results include the commercial launch of the new eye-drops portfolio; Health Canada Remediation plan and production capacity scale-up at Steri-Med progressing as…
Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn
Generic drugmaker Natco Pharma is investing an additional $14 million in U.S.-based biotechnology company eGenesis, which is developing genetically engineered, human-compatible organs for transplantation. The latest investment will be made through…
Drugstores Beat Sun Pharma's $10M Racketeering Suit
A New Jersey federal judge threw out Sun Pharmaceutical Industries Inc.'s suit against a group of pharmacies alleging they engaged in a criminal, years-long racketeering scheme that resulted in it paying... To view the full article, register now.
Dr. Reddy's CDMO arm Aurigene inks long-term manufacturing pact with global pharma major
Contract research, development and manufacturing organisation Aurigene Pharmaceutical Services, a subsidiary of Dr. Reddy's Laboratories, has entered into a long-term manufacturing and supply agreement (MSA) with a leading global pharmaceutical…
Natco Pharma to invest $14 million in eGenesis Inc
Natco Pharma on Tuesday said it is investing $14 million (over ₹130 crore) in eGenesis Inc, a US-based biotechnology firm, through its two subsidiaries. As part of the transaction, Natco Pharma (Canada) Inc will invest $9.5 million and Natco…
NewAmsterdam Pharma (NASDAQ:NAMS) Insider Johannes Jacob Piete Kastelein Sells 125,000 Shares of Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) insider Johannes Jacob Piete Kastelein sold 125,000 shares of the firm's stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $26.91, for a…
Parkman Healthcare Partners LLC Acquires New Position in Urogen Pharma $URGN
Parkman Healthcare Partners LLC acquired a new position in shares of Urogen Pharma (NASDAQ:URGN - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional…
Swiss non-profit drugmakers team up as funding shrinks
• Three Geneva-based non-profit drug developers are pooling resources for R&D, advocacy and communications. • Pharma R&D spending on neglected diseases fell from $824 million in 2018 to $623 million in 2024. • Experts are…
/afaqs/media/media_files/2026/08/25/wpp-2026-08-25-11-35-25.jpg)
WPP Media elevates Kketan Chopra to senior vice president- commerce
Kketan Chopra has been promoted to senior vice president – WPP Commerce at WPP Media. He announced the move in a LinkedIn post. He wrote: 'I'm happy to share that I've been promoted to Senior Vice President – WPP Commerce.' Chopra has…
Navigating Vaccine Guidance
During the Obama administration, he was concerned about vaccines causing autism and it showed when it came to guidance about swine flu vaccines. His administration banned multi-use vials because of his party's insistence that preservatives caused…
If Earnings Growth Returns, Capital Can Flow Back To India
'India is vulnerable to the West Asia crisis in three ways: Energy costs, the business Indian companies conduct in the region, and remittances from the Indian diaspora.' 'Sustained FII selling has hurt largecaps disproportionately because foreign…
Evogene (EVGN) Q2 2026 Earnings Call Transcript
Tuesday, Aug. 18, 2026 at 9:00 a.m. ET Chairman of the Board of Directors - Nir Nimrodi President and CEO - Ofer Haviv VP Finance - Polina Ravzin Cash and Cash Equivalents -- $9.3 million as of June 30, 2026, reflecting the company's current…
Xanadu: Great Science, Too Much Success Priced In (NASDAQ:XNDU)
Xanadu demonstrates credible quantum technology, but current ~$3B valuation overprices the probability of timely technical success. Photon loss remains the core technical hurdle; management estimates a 5–10x gap remains to fault tolerance…
'Give Me Anything But Tech': Jim Cramer's Bold Call on the Market's Next Big Rotation
On CNBC's Squawk on the Street Monday morning, Jim Cramer said the tape has soured on the trade that carried the market for most of the past year. “We're defaulting to all right, give me anything but tech, give me anything but data center.
Receive a Daily briefing on Pharma Industry News
Get Started